Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) shares dropped 1.8% during mid-day trading on Wednesday . The stock traded as low as $0.57 and last traded at $0.57. Approximately 18,721 shares traded hands during trading, a decline of 99% from the average daily volume of 1,286,615 shares. The stock had previously closed at $0.58.
Elevai Labs Price Performance
The company’s fifty day moving average is $0.70.
Elevai Labs (NASDAQ:ELAB – Get Free Report) last issued its quarterly earnings data on Friday, March 29th. The company reported ($0.08) EPS for the quarter. The business had revenue of $0.70 million for the quarter.
About Elevai Labs
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
See Also
- Five stocks we like better than Elevai Labs
- Investing In Automotive Stocks
- United Airlines Soars on Earnings Beat
- What Are Dividend Contenders? Investing in Dividend Contenders
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
